Showing results (31-40 of 216) with videos related to

Sort By:
Pageof 22
British Journal of Cancer|September 29, 2020
First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumoursMalaka Ameratunga, Irene Braña, Petri Bono, et al.
Molecular Cell|July 2, 2026
Cytosolic EZH2-IMPDH2 complexes regulate melanoma progression and metastasis via GTPGamze Kuser-Abali, Fumihito Noguchi, Peinan Zhao, et al.
IEEE Transactions on Systems, Man, and Cybernetics. Part B, Cybernetics : a Publication of the IEEE Systems, Man, and Cybernetics Society|December 26, 2006
Self-organized service orchestration through collective differentiationFabrice Saffre, José Halloy, Mark Shackleton, et al.
Cell|September 10, 2009
Heterogeneity in cancer: cancer stem cells versus clonal evolutionMark Shackleton, Elsa Quintana, Eric R Fearon, et al.
Melanoma Management|December 7, 2019
An update on adjuvant systemic therapies in melanomaEvangeline Samuel, Maggie Moore, Mark Voskoboynik, et al.
Molecular Cancer Therapeutics|February 23, 2017
Calcium-Dependent Enhancement by Extracellular Acidity of the Cytotoxicity of Mitochondrial Inhibitors against MelanomaFumihito Noguchi, Shigeki Inui, Clare Fedele, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique|June 26, 2024
Cancer and social justice: What's advocacy got to do with it?Andrea Knox, Joanne Crawford, Gabriella Wong Ken
Melanoma Research|December 22, 2022
Immune-related adverse events are associated with therapeutic efficacy of immunotherapy in patients with melanoma brain metastasesCecilia W Huo, Indika Gunadasa, Panagiota Gkolia, et al.
Australian Journal of General Practice|February 5, 2021
Reduced melanoma referrals during COVID-19 lockdownWilliam Berry, Katrina Tan, Andrew Haydon, et al.
Pageof 22